As a result, WB-MRI is developing into a first-line imaging modality in MM.
FULL BODY IMAGETYPE PLUS
MRI is a key component of the Durie-Salmon PLUS staging system, and the number of lesions identified on MRI correlates closely with mortality. In recent years, whole body-MRI (WB-MRI) has emerged as a valuable tool for assessing disease activity in multiple myeloma (MM). This work was supported by CRUK/EPSRC KCL/UCL Comprehensive Cancer Imaging Centre.Ĭompeting interests: The authors have declared that no competing interests exist. TJPB is also supported by Arthritis Research UK Grant 21369. MHC, SP, TJPB and ALa are supported by the NIHR University College London Hospitals BRC. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.ĭata Availability: All relevant data are within the paper and its Supporting Information files.įunding: This work was undertaken at UCLH/UCL, which receives funding from the Department of Health’s the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme. Received: FebruAccepted: JPublished: July 3, 2017Ĭopyright: © 2017 Bray et al.
PLoS ONE 12(7):Įditor: Quan Jiang, Henry Ford Health System, UNITED STATES (2017) Diagnostic utility of whole body Dixon MRI in multiple myeloma: A multi-reader study. Citation: Bray TJP, Singh S, Latifoltojar A, Rajesparan K, Rahman F, Narayanan P, et al.
0 kommentar(er)
